ITGA2B and Mental deterioration: The biomarkers of platelet activation such as SELP and ITGA2B/glycoprotein IIb‐ITGB3/glycoprotein IIIa are increased in AD patients with faster cognitive decline compared with those with slow cognitive decline [60].